Abstract:Background: At present, the commercial artificial small diameter (< 6 mm) vascular grafts are still unsatisfactory, due to poor biocompatibility and low long-term patency rate. Objective: This study was to design a novel tissue engineering blood vessel constructed by dog bone marrow derived endothelial progenitor cells and decellularized allogeneic vascular scaffolds. Design, time and setting: From December 2005 to December 2007, the experiment, a randomized control trial of cells an histopathology in vitro, was completed in the Affiliated Drum Tower Hospital of Nanjing University Medical School. Materials: The decellularized canine common carotids were obtained by a detergent-enzymatic procedure; Bone marrow mononuclear cells from mongrel adult dogs were isolated using density gradient centrifugation method and cultured in culture flasks coated with fibronectin. Subsequently, the expanded endothelial progenitor cells were seeded on the decellularized scaffolds, and then co-cultured in the self-made bioreactor to construct the tissue engineering blood vessels. Methods: Bilateral common carotid artery and lateral femoral artery in twenty dogs were all exposed. Three vascular segments from each dog were harvested and then randomly divided into three groups according to the transplant with the tissue engineering blood vessels, decellularized allogeneic vascular scaffolds or autogenous vein. Twenty vessels were implanted into the dogs of each group. Main outcome measures: Immunocytochemical staining was used to identify the cultured endothelial progenitor cells; After 6 months of transplantation, the grafts were retrieved for digital subtraction angiography, pathological test and scanning electron microscope examination. Results: Dog bone marrow mononuclear cells presented a cobblestone-like appearance at 10 days of the culture. The immunocytochemistry results were consistent with the phenotype of endothelial progenitor cells; After highly proliferative endothelial progenitor cells were seeded onto the decellularized scaffold for 10 days, seed cells attached well in the lumen of blood vessels; Six months after implantation, the tissue engineering blood vessels were 85% patent and autogenous vein grafts were 90 patent, which was superior to decellularized allogeneic vascular scaffolds (25%). Conclusion: This study provides a new strategy to develop a tissue engineering blood vessel with excellent biocompatibility and high patency rate by the co-culture of dog bone marrow derived endothelial progenitor cells with decellularized vascular scaffolds.

Functional Tissue-Engineered Blood Vessels from Bone Marrow Progenitor Cells.

An Experimental Research on Construction of Tissue Engineering Blood Vessel Scaffold with Cells from Bone Marrow Mononuclear Cells

Derivation of Functional Smooth Muscle Cells from Integration-Free Induced Pluripotent Stem Cells Through Cardiovascular Progenitor Cell Intermediates for Vascular Regeneration

Tissue Engineering of Blood Vessels: Characterization of Smooth-Muscle Cells for Culturing on Collagen-And-Elastin-Based Scaffolds

Differentiation of smooth muscle progenitor cells in peripheral blood and its application in tissue engineered blood vessels

Hair Follicle-Derived Smooth Muscle Cells and Small Intestinal Submucosa for Engineering Mechanically Robust and Vasoreactive Vascular Media.

Functional and ultrastructural analysis of endothelial-like cells derived from bone marrow stromal cells.

Engineering Vascular Tissue with Functional Smooth Muscle Cells Derived from Human Ips Cells and Nanofibrous Scaffolds.

Tissue Engineering of Blood Vessels with Endothelial Cells Differentiated from Mouse Embryonic Stem Cells

Engineering Blood Vessels Through Micropatterned Co-Culture of Vascular Endothelial and Smooth Muscle Cells on Bilayered Electrospun Fibrous Mats with Pdna Inoculation.

Smooth Muscle Cells Differentiated from Reprogrammed Embryonic Lung Fibroblasts Through DKK3 Signaling Are Potent for Tissue Engineering of Vascular Grafts.

Abstract 650: Stem Cell-derived SMCs Are Useful for Vascular Tissue Engineering

Abstract 302: Generation of Patient-Specific Tissue-Engineered Blood Vessels from Nonintegrated Induced Pluripotent Stem Cells

A completely biological tissue‐engineered human blood vessel

Tissue-Engineered Grafts Constructed Using Bone Marrow-Derived Mesenchymal Stem Cells and Vascular Acellular Matrices

A small diameter elastic blood vessel wall prepared under pulsatile conditions from polyglycolic acid mesh and smooth muscle cells differentiated from adipose-derived stem cells.

The Development of a Tissue-Engineered Artery Using Decellularized Scaffold and Autologous Ovine Mesenchymal Stem Cells

Endothelialized microvessels fabricated by microfluidics facilitate osteogenic differentiation and promote bone repair

Contractile Smooth Muscle Cells Derived from Hair-Follicle Stem Cells.

Tissue-engineered blood vessels constructed by bone marrow-derived endothelial progenitor cells and decellularized vascular scafflolds

Construction of Vascular Tissues with Macro-Porous Nano-Fibrous Scaffolds and Smooth Muscle Cells Enriched from Differentiated Embryonic Stem Cells.